FREE SHIPPING over $40
OVER 9000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
Home / Equine Research Bank / Equine Vet J / Clinical signs, clinical pathology and outcomes in horses in...
Equine veterinary journal2025; 58(2); 434-443; doi: 10.1111/evj.70117

Clinical signs, clinical pathology and outcomes in horses infected naturally with equine encephalosis virus.

Abstract: Equine encephalosis (EE) is caused by an Orbivirus from the family Sedoreoviridae and is thus similar to African horse sickness (AHS) and Bluetongue viruses (BTV). These viruses are transmitted by Culicoides midges. Equine encephalosis can infect horses, donkeys and zebras sub-clinically while only horses develop clinical disease. The vector's distribution is climate-dependent with evidence for circulation in Southern Africa, the Middle East and India. Global warming could facilitate the expansion of this distribution and consequently the potential spread into Europe should not be overlooked. Objective: To describe clinical signs, clinicopathological abnormalities, and outcomes in horses naturally infected with EE. Methods: A retrospective, descriptive, observational study. Methods: Data were obtained from the Onderstepoort Veterinary Academic Hospital's clinical database to identify cases with EE from 2013 to 2023. Data including the history, clinical signs and clinicopathology were analysed. Results: Equine encephalosis cases predominantly occurred from February to April. Twenty-five horses were included. Throughout the disease, 25 (100.0%) horses had pyrexia (mean maximum temperature 39.3°C; SD 0.86°C), 16 (64.0%) horses had tachycardia (median maximum heart rate 52/min; range 36-100/min), 19 (76.0%) horses had tachypnoea (median maximum respiratory rate 24/min; range 12-60/min). Within 24 h of presentation, horses predominantly displayed lymphopenia (median 1.17 × 10 cells/L; range 0.15-9.21 × 10 cells/L), thrombocytopenia (median 67.5 × 10 cells/L; range 3-303 × 10 cells/L), and leukopenia (median 5.44 × 10 cells/L; range 2.08-18.07 × 10 cells/L). Conclusions: Retrospective study design with a small number of cases and many of these evaluated at differing times after infection. Conclusions: Pyrexia, tachycardia and tachypnoea are the most common clinical signs associated with EE. Haematological evaluation appears valuable in EE cases, with leukopenia, lymphopenia, and thrombocytopenia commonly observed. Equine encephalosis is a relevant differential diagnosis for other infectious diseases in horses in geographical regions where EEV and Culicoides vectors are potentially present.
© 2025 The Author(s). Equine Veterinary Journal published by John Wiley & Sons Ltd on behalf of EVJ Ltd.
Get Full Text
Publication Date: 2025-11-14 PubMed ID: 41235818PubMed Central: PMC12892390DOI: 10.1111/evj.70117Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

Overview

  • This study investigated the clinical signs, blood abnormalities, and outcomes in horses naturally infected with equine encephalosis virus (EEV), a virus related to African horse sickness and Bluetongue virus and transmitted by midges.
  • It aimed to characterize how horses present when infected and highlight the importance of recognizing EE as a differential diagnosis in regions where the virus and its vectors exist or may expand to due to climate change.

Background

  • Equine encephalosis (EE) is caused by the equine encephalosis virus (EEV), an Orbivirus from the Sedoreoviridae family.
  • EEV is closely related to African horse sickness virus (AHS) and Bluetongue virus (BTV), which are also transmitted by Culicoides midges.
  • While donkeys and zebras can carry the virus without showing symptoms, only horses develop clinical disease.
  • The distribution of Culicoides midges is dependent on climate, with known circulation in Southern Africa, the Middle East, and India.
  • Climate change and global warming could facilitate the geographical expansion of Culicoides, potentially introducing the virus to new regions such as Europe.

Objective

  • To describe in detail the clinical signs, laboratory blood test abnormalities (clinicopathology), and outcomes in horses naturally infected with EEV.

Methods

  • A retrospective, descriptive, observational study design was used.
  • Data were collected from the Onderstepoort Veterinary Academic Hospital’s clinical database for the years 2013 to 2023.
  • Horses diagnosed with EE during this period were identified, and their clinical histories, examination findings, and laboratory blood test results were analyzed.
  • Both clinical signs and clinicopathological parameters were documented to characterize the disease presentation.

Results

  • A total of 25 horses with EE infection were included in the study.
  • The majority of cases occurred seasonally, primarily between February and April, aligning with peak vector activity periods.
  • Common clinical signs included:
    • Pyrexia (fever) in 100% of cases, with an average max temperature of 39.3°C (normal horse temperature is roughly 37.5-38.5°C).
    • Tachycardia (increased heart rate) in 64% of horses, with median maximum heart rate of 52 beats per minute (normal resting rate is ~28-40 bpm).
    • Tachypnoea (increased respiratory rate) in 76% of cases, median max respiratory rate 24 breaths per minute (normal ~8-15 bpm).
  • Common clinicopathological abnormalities observed within 24 hours of presentation included:
    • Lymphopenia (reduced lymphocytes) median 1.17 ×10^9 cells/L (normal range varies but typically higher in healthy horses).
    • Thrombocytopenia (reduced platelets) median 67.5 ×10^9 cells/L.
    • Leukopenia (reduced white blood cells) median 5.44 ×10^9 cells/L.

Conclusions

  • Despite the retrospective design and relatively small sample size, the study provides valuable insights into the clinical presentation of EE in horses.
  • Fever, increased heart rate, and increased respiratory rate are the most consistent clinical signs and should raise suspicion for EE in appropriate geographical and seasonal contexts.
  • Hematological evaluation is important in diagnosing and assessing EE, with a characteristic pattern of reduced white blood cells, lymphocytes, and platelets.
  • Clinicians should include equine encephalosis as a key differential diagnosis when horses present with fever and hematologic abnormalities in areas where EEV vectors exist or could spread.
  • The potential geographic expansion of the virus due to climate change underscores the importance of surveillance and awareness.

Cite This Article

APA
Piketh G, Viljoen A, Eberhardt C. (2025). Clinical signs, clinical pathology and outcomes in horses infected naturally with equine encephalosis virus. Equine Vet J, 58(2), 434-443. https://doi.org/10.1111/evj.70117

Publication

Equine veterinary journal
ISSN: 2042-3306
NlmUniqueID: 0173320
Country: United States
Language: English
Volume: 58
Issue: 2
Pages: 434-443

Researcher Affiliations

Piketh, Graeme
  • Department of Companion Animal Clinical Studies, Faculty of Veterinary Science, University of Pretoria, Onderstepoort, South Africa.
Viljoen, Adrienne
  • Department of Companion Animal Clinical Studies, Faculty of Veterinary Science, University of Pretoria, Onderstepoort, South Africa.
Eberhardt, Christina
  • Department of Companion Animal Clinical Studies, Faculty of Veterinary Science, University of Pretoria, Onderstepoort, South Africa.

MeSH Terms

  • Animals
  • Horses
  • Horse Diseases / virology
  • Horse Diseases / pathology
  • Retrospective Studies
  • Orbivirus
  • Male
  • Female

Conflict of Interest Statement

The authors declare no conflicts of interest.

References

This article includes 43 references
  1. Aharonson‐Raz K, Steinman A, Kavkovsky A, Bumbarov V, Berlin D, Lichter‐Peled A. Analysis of the Association of Climate, Weather and Herd Immunity with the spread of equine encephalosis virus in horses in Israel. Transbound Emerg Dis 2017;64(2):593–602.
    doi: 10.1111/tbed.12424pubmed: 26392206google scholar: lookup
  2. Gordon SJG, Bolwell C, Rogers CW, Musuka G, Kelly P, Guthrie A. The sero‐prevalence and sero‐incidence of African horse sickness and equine encephalosis in selected horse and donkey populations in Zimbabwe. Onderstepoort J Vet Res 2017;84:1–5.
    doi: 10.4102/ojvr.v84i1.1445pmc: PMC6238669pubmed: 28582979google scholar: lookup
  3. Oura CAL, Batten CA, Ivens PAS, Balcha M, Alhassan A, Gizaw D. SHORT REPORT: equine encephalosis virus: evidence for circulation beyond southern Africa. Epidemiol Infect 2012;140(11):1982–1986.
    pubmed: 22166372
  4. Paweska JT, Venter GJ. Vector competence of Culicoides species and the seroprevalence of homologous neutralizing antibody in horses for six serotypes of equine encephalosis virus (EEV) in South Africa. Med Vet Entomol 2004;18(4):398–407.
    doi: 10.1111/j.0269-283X.2004.00524pubmed: 15642007google scholar: lookup
  5. Tirosh‐Levy S, Gelman B, Zivotofsky D, Quraan L, Khinich E, Nasereddin A. Seroprevalence and risk factor analysis for exposure to equine encephalosis virus in Israel, Palestine and Jordan. Vet Med Sci 2017;3:82–90.
    doi: 10.1002/vms3.58pmc: PMC5488184pubmed: 28713576google scholar: lookup
  6. Theiler A. Notes on a fever in horses simulating horse‐sickness. Transvaal Agric J 1910;8(32):581–586.
    doi: 10.10520/AJA0000010_644google scholar: lookup
  7. Walker PJ, Siddell SG, Lefkowitz EJ, Mushegian AR, Adriaenssens EM, Alfenas‐Zerbini P. Recent changes to virus taxonomy ratified by the International Committee on Taxonomy of Viruses (2022). Arch Virol 2022;167(11):2429–2440.
    doi: 10.1007/s00705-022-05516-5pmc: PMC10088433pubmed: 35999326google scholar: lookup
  8. Viljoen GJ, Huismans H. The characterization of equine encephalosis virus and the development of genomic probes. J Gen Virol 1989;70(Pt 8):2007–2015.
    doi: 10.1099/0022-1317-70-8-2007pubmed: 2549180google scholar: lookup
  9. Campbell CL, Wilson WC. Differentially expressed midgut transcripts in (Diptera: Ceratopogonidae) following Orbivirus (Reoviridae) oral feeding. Insect Mol Biol 2002;11:595–604.
    doi: 10.1046/j.1365-2583.2002.00370.xpubmed: 12421417google scholar: lookup
  10. Yadav PD, Albariño CG, Nyayanit DA, Guerrero L, Jenks M, Sarkale P. Equine encephalosis virus in India, 2008. Emerg Infect Dis 2018;24(5):898–901.
    doi: 10.3201/eid2405.171844pmc: PMC5938759pubmed: 29664366google scholar: lookup
  11. Baylis M, Mellor PS, Meiswinkel R. Horse sickness and ENSO in South Africa. Nature 1999;397(6720):574.
    doi: 10.1038/17512pubmed: 10050850google scholar: lookup
  12. Venter GJ, Groenewald D, Venter E, Hermanides KG, Howell PG. A comparison of the vector competence of the biting midges, Culicoides (Avaritia) bolitinos and C. (A.) imicola, for the Bryanston serotype of equine encephalosis virus. Med Vet Entomol 2002;16(4):372–377.
    doi: 10.1046/j.1365-2915.2002.00385.xpubmed: 12510889google scholar: lookup
  13. Howell PG, Nurton JP, Nel D, Lourens CW, Guthrie AJ. Prevalence of serotype specific antibody to equine encephalosis virus in thoroughbred yearlings in South Africa (1999–2004). Onderstepoort J Vet Res 2008;75:153–161.
    pubmed: 18788209
  14. Nicolas G, Tisseuil C, Conte A, Allepuz A, Pioz M, Lancelot R. Environmental heterogeneity and variations in the velocity of bluetongue virus spread in six European epidemics. Prev Vet Med 2018;149:1–9.
    doi: 10.1016/j.prevetmed.2017.11.005pubmed: 29290289google scholar: lookup
  15. Leta S, Fetene E, Mulatu T, Amenu K, Jaleta MB, Beyene TJ. Modeling the global distribution of Culicoides imicola: an ensemble approach. Sci Rep 2019;9:14187.
    doi: 10.1038/s41598-019-50765-1pmc: PMC6775326pubmed: 31578399google scholar: lookup
  16. Mellor PS, Boorman J, Baylis M. Culicoides biting midges: their role as arbovirus vectors. Annu Rev Entomol 2000;45:307–340.
    doi: 10.1146/annurev.ento.45.1.307pubmed: 10761580google scholar: lookup
  17. Faverjon C, Leblond A, Lecollinet S, Bødker R, de Koeijer AA, Fischer EAJ. Comparative risk analysis of two ‐borne diseases in horses: equine encephalosis more likely to enter France than African horse sickness. Transbound Emerg Dis 2017;64:1825–1836.
    doi: 10.1111/tbed.12577pubmed: 27658808google scholar: lookup
  18. Zimmerli U, Herholz C, Schwermer H, Hofmann M, Griot C. Afrikanische Pferdepest und equine Encephalosis: Muss sich die Schweiz vorbereiten? [African horse sickness and equine encephalosis: must Switzerland get prepared]. Schweiz Arch Tierheilkd 2010;152(4):165–175.
    doi: 10.1024/0036-7281/a000039pubmed: 20361395google scholar: lookup
  19. Fischer EAJ, Martínez López EP, De Vos CJ, Faverjon C. Quantitative analysis of the probability of introducing equine encephalosis virus (EEV) into the Netherlands. Prev Vet Med 2016;131:48–59.
    doi: 10.1016/j.prevetmed.2016.07.005pubmed: 27544251google scholar: lookup
  20. Huismans H, Staden VV, Fick W, Niekerk ML, Meiring TL. A comparison of different orbivirus proteins that could affect virulence and pathogenesis. Veterinaria Ital 2004;40(4):417–425.
    pubmed: 20422564
  21. Gould AR, Hyatt AD. The orbivirus genus. Diversity, structure, replication and phylogenetic relationships. Comp Immunol Microbiol Infect Dis 1994;17(3):163–188.
    doi: 10.1016/0147-9571(94)90041-8pubmed: 8001343google scholar: lookup
  22. Snyman J, Koekemoer O, van Schalkwyk A, Jansen van Vuren P, Snyman L, Williams J. Epidemiology and genomic analysis of equine encephalosis virus detected in horses with clinical signs in South Africa, 2010–2017. Viruses 2021;13:398.
    doi: 10.3390/v13030398pmc: PMC8001977pubmed: 33801457google scholar: lookup
  23. Howell P, Groenewald D, Visage C, Bosman A‐M, Coetzer J, Guthrie A. The classification of seven serotypes of equine encephalosis virus and the prevalence of homologous antibody in horses in South Africa. Onderstepoort J Vet Res 2002;69:79–93.
    pubmed: 12092781
  24. Erasmus B, Adelaar T, Smit J, Lecatsas G, Toms T. The isolation and characterization of equine encephalosis virus. Bull Off Int Epizoot 1970;74:781–789.
  25. Grewar JD, Thompson PN, Lourens CW, Guthrie AJ. Equine encephalosis in thoroughbred foals on a South African stud farm. Onderstepoort J Vet Res 2015;82:966.
    doi: 10.4102/ojvr.v82i1.966pmc: PMC6238798pubmed: 26842364google scholar: lookup
  26. Erasmus BJ, Boshoff ST, Pieterse LM. The isolation and characterization of equine encephalosis and serologically related orbiviruses from horses. J Equine Med Surg 1978;1(Suppl):447–450.
  27. Mildenberg Z, Westcott D, Bellaiche M, Dastjerdi A, Steinbach F, Drew T. Equine encephalosis virus in Israel. Transbound Emerg Dis 2009;56(8):291.
    doi: 10.1111/j.1865-1682.2009.01087_1.xpubmed: 19744233google scholar: lookup
  28. Aharonson‐Raz K, Steinman A, Bumbarov V, Maan S, Maan NS, Nomikou K. Isolation and phylogenetic grouping of equine encephalosis virus in Israel. Emerg Infect Dis 2011;17(10):1883–1886.
    doi: 10.3201/eid1710.110350pmc: PMC3310674pubmed: 22000361google scholar: lookup
  29. Wescott DG, Mildenberg Z, Bellaiche M, McGowan SL, Grierson SS, Choudhury B. Evidence for the circulation of equine encephalosis virus in Israel since 2001. PLoS One 2013;8(8):e70532.
    doi: 10.1371/journal.pone.0070532pmc: PMC3741287pubmed: 23950952google scholar: lookup
  30. Tirosh‐Levy S, Steinman A. Equine encephalosis virus. Animals (Basel) 2022;12(3):337.
    doi: 10.3390/ani12030337pmc: PMC8833465pubmed: 35158658google scholar: lookup
  31. Rathogwa NM, Quan M, Smit JQ, Lourens C, Guthrie AJ, van Vuuren M. Development of a real time polymerase chain reaction assay for equine encephalosis virus. J Virol Methods 2014;195:205–210.
    doi: 10.1016/j.jviromet.2013.10.018pubmed: 24161811google scholar: lookup
  32. nBayly WM, Sellon DC, Reed SM. Equine internal medicine—e‐book. St. Loius, MO: Elsevier Health Sciences; 2009. [cited 2025 May 6]. Available from: https://books.google.co.za/books?id=JBF5jlaRClcCn
  33. Lascola KM, Vander Werf K, Freese S, Morgera A, Schaeffer DJ, Wilkins P. Comparison of jugular and transverse facial venous sinus blood analytes in healthy and critically ill adult horses. J Vet Emerg Crit Care 2017;27(2):198–205.
    doi: 10.1111/vec.12588pubmed: 28207993google scholar: lookup
  34. Schliewert EC, Hooijberg EH, Steyn JS, Potgieter C, Fosgate GT, Goddard A. Experimental infection with African horse sickness virus in horses induces only mild temporal hematologic changes and acute phase reactant response. Am J Vet Res 2022;83(11):1–11.
    doi: 10.2460/ajvr.22.08.0123pubmed: 36215210google scholar: lookup
  35. Steyn J, Venter G, Labuschagne K, Majatladi D, Boikanyo S, Lourens C. Possible over‐wintering of bluetongue virus in populations in the Onderstepoort area, Gauteng, South Africa. J S Afr Vet Assoc 2016;87(1):e1–e5.
    doi: 10.4102/jsava.v87i1.1371pmc: PMC6138179pubmed: 28155292google scholar: lookup
  36. Long MT, Guthrie AJ. Chapter 16—African horse sickness. In: Sellon DC, Long MT, editors. Equine infectious diseases. 2nd ed. St. Louis, MO: W.B. Saunders; 2014. p. 181–188.e4.
    doi: 10.1016/B978-1-4557-0891-8.00016-6google scholar: lookup
  37. Skowronek AJ, LaFranco L, Stone‐Marschat MA, Burrage TG, Rebar AH, Laegreid WW. Clinical pathology and hemostatic abnormalities in experimental African horsesickness. Vet Pathol 1995;32(2):112–121.
    doi: 10.1177/030098589503200203pubmed: 7771050google scholar: lookup
  38. Jaynudin K, Singh K, Bhatt P, Saminathan M, Tiwari S, Bhat S. Haematological and biochemical alterations in native sheep experimentally infected with bluetongue virus serotype‐2. Indian J Anim Sci 2019;89:3–8.
    doi: 10.56093/ijans.v89i1.86230google scholar: lookup
  39. Sheats MK. A comparative review of equine SIRS, sepsis, and neutrophils. Front Vet Sci 2019;6:69–88.
    pmc: PMC6424004pubmed: 30931316
  40. Clift S, Penrith M. Tissue and cell tropism of African horse sickness virus demonstrated by immunoperoxidase labeling in natural and experimental infection in horses in South Africa. Vet Pathol 2010;47:690–697.
    doi: 10.1177/0300985810370010pubmed: 20484177google scholar: lookup
  41. Russell H, O'Toole DT, Bardsley K, Davis WC, Ellis JA. Comparative effects of bluetongue virus infection of ovine and bovine endothelial cells. Vet Pathol 1996;33(3):319–331.
    doi: 10.1177/030098589603300309pubmed: 8740706google scholar: lookup
  42. Sellon D, Wise L. Disorders of the hematopoietic system. Equine Intern Med. St. Louis, MO: Elsevier Health Sciences; 2010. p. 730–776.
  43. Sellon DC. Thrombocytopenia in horses. Equine Vet Educ 1998;10(3):133–139.
    doi: 10.1111/j.2042-3292.1998.tb00865.xgoogle scholar: lookup

Citations

This article has been cited 0 times.
Subscribe to our newsletter
Join 99,005 horse owners like you who receive our email updates on horse health and nutrition.